🇨🇦 NKT2152 in Canada

NKT2152 (nkt2152) regulatory status in Canada.

Marketing authorisation

NKT2152 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Canada

Frequently asked questions

Is NKT2152 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for NKT2152 in Canada?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.